Prenatal programming of the innate immune response following in utero exposure to inflammation: A sexually dimorphic process?

Expert Review of Clinical Immunology

Volumn 7, Issue 5, 2011, Pages 579-592

  Hodyl, Nicolette A ^a   Stark, Michael J ^a   Osei Kumah, Annette ^a   Clifton, Vicki L ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

fetal; fetal origins of disease; in utero; inflammation; maternal inflammation; neonate; prenatal programming

Indexed keywords

C REACTIVE PROTEIN; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROBIOTIC AGENT; RANTES; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR;

ADAPTIVE IMMUNITY; ATOPIC DERMATITIS; BACTERIAL INFECTION; BINDING AFFINITY; BRAIN HEMORRHAGE; CHORIOAMNIONITIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; FETUS LUNG MATURATION; HUMAN; INNATE IMMUNITY; INTRAUTERINE INFECTION; LOW BIRTH WEIGHT; MALARIA; MATERNAL DISEASE; MATERNAL NUTRITION; MOUTH HYGIENE; NECROTIZING ENTEROCOLITIS; NEWBORN INFECTION; NONHUMAN; NUCLEAR REPROGRAMMING; PATTERN RECOGNITION; PERIODONTAL DISEASE; PLACENTA FUNCTION; PREMATURE LABOR; PREMATURITY; PRENATAL EXPOSURE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SEX DIFFERENCE; SPONTANEOUS ABORTION; STILLBIRTH; SURVIVAL RATE; TH1 TH2 BALANCE; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; FEMALE; HUMANS; IMMUNITY, INNATE; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFLAMMATION; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEX CHARACTERISTICS;

EID: 80052609097     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.11.51     Document Type: Review

References (211)

1. Gluckman PD, Hanson MA. Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Pediatr. Res. 56(3), 311-317 (2004). (Pubitemid 39128811)
2. Flanagan KL, Halliday A, Burl S et al. The effect of placental malaria infection on cord blood and maternal immunoregulatory responses at birth. Eur. J. Immunol. 40(4), 1062-1072 (2010).
3. Hodyl NA, Krivanek KM, Clifton VL, Hodgson DM. Innate immune dysfunction in the neonatal rat following prenatal endotoxin exposure. J. Neuroimmunol. 204(1-2), 126-130 (2008).
4. Kramer BW, Ikegami M, Moss TJ, Nitsos I, Newnham JP, Jobe AH. Endotoxin-induced chorioamnionitis modulates innate immunity of monocytes in preterm sheep. Am. J. Respir. Crit. Care Med. 171(1), 73-77 (2005). (Pubitemid 40051698)
5. Prescott SL, Clifton V. Asthma and pregnancy: emerging evidence of epigenetic interactions in utero. Curr. Opin. Allergy Clin. Immunol. 9(5), 417-426 (2009).
6. Warner JA, Jones CA, Williams TJ, Warner JO. Maternal programming in asthma and allergy. Clin. Exp. Allergy 28(Suppl. 5), 35-38; discussion 50-31 (1998).
7. Hodyl NA, Krivanek KM, Lawrence E, Clifton VL, Hodgson DM. Prenatal exposure to a proinflammatory stimulus causes delays in the development of the innate immune response to LPS in the offspring. J. Neuroimmunol. 190(1-2), 61-71 (2007). (Pubitemid 47625608)
8. Beloosesky R, Maravi N, Weiner Z et al. Maternal lipopolysaccharide- induced inflammation during pregnancy programs impaired offspring innate immune responses. Am. J. Obstet. Gynecol. 203(2), 185, e181-e184 (2010).
9. Manzoni P, Rizzollo S, Decembrino L et al. Recent advances in prevention of sepsis in the premature neonates in NICU. Early Hum. Dev. 87(Suppl. 1), S31-S33 (2011).
10. Sohn AH, Garrett DO, Sinkowitz- Cochran RL et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J. Pediatr. 139(6), 821-827 (2001). (Pubitemid 34014461)
11. Stoll BJ, Hansen N, Fanaroff AA et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110(2 Pt 1), 285-291 (2002). (Pubitemid 34833012)
12. Fanaroff AA, Korones SB, Wright LL et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr. Infect. Dis. J. 17(7), 593-598 (1998). (Pubitemid 28340869)
13. Stoll BJ, Hansen N, Fanaroff AA et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N. Engl. J. Med. 347(4), 240-247 (2002). (Pubitemid 34787630)
14. Hack M, Wilson-Costello D, Friedman H, Taylor GH, Schluchter M, Fanaroff AA. Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g: 1992-1995. Arch. Pediatr. Adolesc. Med. 154(7), 725-731 (2000). (Pubitemid 30437556)
15. Goncalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment. Retard. Dev. Disabil. Res. Rev. 8(1), 3-13 (2002). (Pubitemid 34754487)
16. Kotiranta-Ainamo A, Apajasalo M, Pohjavuori M, Rautonen N, Rautonen J. Mononuclear cell subpopulations in preterm and full-term neonates: independent effects of gestational age, neonatal infection, maternal pre-eclampsia, maternal betamethason therapy, and mode of delivery. Clin. Exp. Immunol. 115(2), 309-314 (1999). (Pubitemid 29052457)
17. Forster-Waldl E, Sadeghi K, Tamandl D et al. Monocyte Toll-like receptor 4 expression and LPS-induced cytokine production increase during gestational aging. Pediatr. Res. 58(1), 121-124 (2005). (Pubitemid 40967441)
18. Hartel C, Osthues I, Rupp J et al. Characterisation of the host inflammatory response to Staphylococcus epidermidis in neonatal whole blood. Arch. Dis. Child Fetal Neonatal Ed. 93(2), F140-F145 (2008). (Pubitemid 352038505)
19. Mainali ES, Kikuchi T, Tew JG. Dexamethasone inhibits maturation and alters function of monocyte-derived dendritic cells from cord blood. Pediatr. Res. 58(1), 125-131 (2005). (Pubitemid 40967442)
20. Marodi L. Innate cellular immune responses in newborns. Clin. Immunol. 118, 137-144 (2006). (Pubitemid 43199650)
21. Wynn JL, Scumpia PO, Delano MJ et al. Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock 28(6), 675-683 (2007). (Pubitemid 350135472)
22. Wynn JL, Scumpia PO, Winfield RD et al. Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 112(5), 1750-1758 (2008).
23. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7(5), 379-390 (2007). (Pubitemid 46674489)
24. Currie AJ, Curtis S, Strunk T et al. Preterm infants have deficient monocyte and lymphocyte cytokine responses to group B streptococcus. Infect. Immun. 79(4), 1588-1596 (2011).
25. Belderbos ME, van Bleek GM, Levy O et al. Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clin. Immunol. 133(2), 228-237 (2009).
26. Levy O, Zarember KA, Roy RM, Cywes C, Godowski PJ, Wessels MR. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-a induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J. Immunol. 173(7), 4627-4634 (2004). (Pubitemid 39280696)
27. Yan SR, Qing G, Byers DM, Stadnyk AW, Al-Hertani W, Bortolussi R. Role of MyD88 in diminished tumor necrosis factor a production by newborn mononuclear cells in response to lipopolysaccharide. Infect. Immun. 72(3), 1223-1229 (2004). (Pubitemid 38263739)
28. Nitsche A, Zhang M, Clauss T, Siegert W, Brune K, Pahl A. Cytokine profiles of cord and adult blood leukocytes: differences in expression are due to differences in expression and activation of transcription factors. BMC Immunol. 8, 18 (2007).
29. Firth MA, Shewen PE, Hodgins DC. Passive and active components of neonatal innate immune defenses. Anim. Health Res. Rev. 6(2), 143-158 (2005).
30. Jones CA, Holloway JA, Warner JO. Phenotype of fetal monocytes and B lymphocytes during the third trimester of pregnancy. J. Reprod. Immunol. 56(1-2), 45-60 (2002). (Pubitemid 34754355)
31. Carr R. Neutrophil production and function in newborn infants. Br. J. Haematol. 110(1), 18-28 (2000). (Pubitemid 30625592)
32. Yost CC, Cody MJ, Harris ES et al. Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. Blood 113(25), 6419-6427 (2009).
33. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol. Today 14(7), 353-356 (1993). (Pubitemid 23198169)
34. Adkins B. Development of neonatal Th1/ Th2 function. Int. Rev. Immunol. 19(2-3), 157-171 (2000). (Pubitemid 30231096)
35. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 353(9148), 196-200 (1999). (Pubitemid 29088031)
36. Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168(2), 554-561 (2002). (Pubitemid 34049553)
37. Viemann D, Dubbel G, Schleifenbaum S, Harms E, Sorg C, Roth J. Expression of Toll-like receptors in neonatal sepsis. Pediatr. Res. 58(4), 654-659 (2005). (Pubitemid 41368892)
38. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. TRAF6 is a signal transducer for interleukin-1. Nature 383(6599), 443-446 (1996). (Pubitemid 26330834)
39. Li Q, Verma IM. NF-kB regulation in the immune system. Nat. Rev. Immunol. 2(10), 725-734 (2002).
40. Sadowski HB, Shuai K, Darnell JE Jr, Gilman MZ. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261(5129), 1739-1744 (1993). (Pubitemid 23332924)
41. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81(1), 1-5 (2007). (Pubitemid 46028489)
42. Abrahams VM. The role of the Nod-like receptor family in trophoblast innate immune responses. J. Reprod. Immunol. 88(2), 112-117 (2011).
43. Yin Y, Yan Y, Jiang X et al. Inflammasomes are differentially expressed in cardiovascular and other tissues. Int. J. Immunopathol. Pharmacol. 22(2), 311-322 (2009).
44. Lennartz MR, Cole FS, Shepherd VL, Wileman TE, Stahl PD. Isolation and characterization of a mannose-specific endocytosis receptor from human placenta. J. Biol. Chem. 262(21), 9942-9944 (1987). (Pubitemid 17103056)
45. Chelvarajan RL, Collins SM, Doubinskaia IE et al. Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens. J. Leukoc. Biol. 75(6), 982-994 (2004). (Pubitemid 38720638)
46. Angelone DF, Wessles MR, Coughlin M et al. Innate immunity of the human newborn is polarised toward a high ratio of IL-6/TNF-a production in vitro and in-vivo. Pediatric Res. 60(2), 205-209 (2006). (Pubitemid 44297594)
47. Burl S, Townend J, Njie-Jobe J et al. Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants. PLoS ONE 6(4), e18185 (2011).
48. Levy O. Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists. J. Endotox. Res. 11(2), 113-116 (2005). (Pubitemid 40711487)
49. Noakes PS, Hale J, Thomas R, Lane C, Devadason SG, Prescott SL. Maternal smoking is associated with impaired neonatal Toll-like-receptor-mediated immune responses. Eur. Res. J. 28, 721-729 (2006). (Pubitemid 46331991)
50. Tulic MK, Hodder M, Forsberg A et al. Differences in innate immune function between allergic and nonallergic children: New insights into immune ontogeny. J. Allergy Clin. Immunol. 127(2), 470-478 e1 (2011).
51. Yerkovich ST, Wikstrom ME, Suriyaarachchi D, Prescott SL, Upham JW, Holt PG. Postnatal development of monocyte cytokine responses to bacterial lipopolysaccharide. Pediatr. Res. 62(5), 547-552 (2007). (Pubitemid 351338988)
52. + blood monocytes: their role in infection and inflammation. J. Leukoc. Biol. 81(3), 584-592 (2007). (Pubitemid 46393535)
53. Hasegawa K, Ichiyama T, Isumi H, Nakata M, Sase M, Furukawa S. NF-kB activation in peripheral blood mononuclear cells in neonatal asphyxia. Clin. Exp. Immunol. 132, 261-264 (2003). (Pubitemid 36560621)
54. Sadeghi K, Berger A, Langgartner M et al. Immaturity of infection control in preterm and term newborns is associated with impaired Toll-like receptor signaling. J. Infect. Dis. 195, 296-302 (2007). (Pubitemid 46080062)
55. Mold JE, Michaelsson J, Burt TD et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 322(5907), 1562-1565 (2008).
56. De Wit D, Tonon S, Olislagers V et al. Impaired responses to Toll-like receptor 4 and Toll-like receptor 3 ligands in human cord blood. J. Autoimmun. 21, 277-281 (2003). (Pubitemid 37410116)
57. Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 103(4 Pt 1), 766-771 (1999). (Pubitemid 29274469)
58. Reichlin S. Neuroendocrine-immune interactions. N. Engl. J. Med. 329(17), 1246-1253 (1993).
59. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50(4), 515-525 (1972).
60. Kavelaars A, Cats B, Visser GH et al. Ontogency of the responses of human peripheral blood T cells to glucocorticoids. Brain Behav. Immun. 10(3), 288-297 (1996). (Pubitemid 27007855)
61. Barker DJP. The fetal origins of adult disease. Fetal. Mat. Med. Rev. 6, 71-80 (1994). (Pubitemid 24231817)
62. Phillips DIW, Barker DJP, Fall CHD, Seckl JR, Whorwood CB, Wood PJ. Elevated plasma cortisol concentrations: a link between low birth weight and insulin resistance syndrome. J. Clin. Endocrinol. Metab. 83, 757-760 (1998). (Pubitemid 28496441)
63. Pincus-Knackstedt MK, Joachim RA, Blois SM et al. Prenatal stress enhances susceptibility of murine adult offspring toward airway inflammation. J. Immunol. 177(12), 8484-8492 (2006). (Pubitemid 44893811)
64. Ege MJ, Herzum I, Buchele G et al. Prenatal exposure to a farm environment modifies atopic sensitization at birth. J. Allergy Clin. Immunol. 122(2), 407-412, e1-e4 (2008).
65. Phillips DI. External influences on the fetus and their long-term consequences. Lupus 15(11), 794-800 (2006).
66. Dahri S, Snoeck A, Reusens-Billen B, Remacle C, Hoet J. Islet function in offspring of mothers on low-protein diet during gestation. Diabetes 40(Suppl. 2), 115-120 (1991).
67. Langley SC, Jackson AA. Increased systolic blood pressure in adult rats induced by fetal exposure to low protein diets. Clin. Sci. 86, 217-222 (1994). (Pubitemid 24056702)
68. Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A, Seckl JR. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J. Clin. Invest. 101, 2174-2181 (1998). (Pubitemid 28244101)
69. Jansson T, Lambert G. Effect of intrauterine growth restriction on blood pressure, glucose tolerance and sympathetic nervous system activity in the rat at 3-4 months of age. J. Hypertens. 17, 1239-1248 (1999). (Pubitemid 29509501)
70. Simmons RA, Templeton LJ, Gertz SJ. Intrauterine growth retardation leads to the development of Type 2 diabetes in the rat. Diabetes 50, 2279-2286 (2001). (Pubitemid 33641912)
71. Douwes J, Cheng S, Travier N et al. Farm exposure in utero may protect against asthma, hay fever and eczema. Eur. Respir. J. 32(3), 603-611 (2008).
72. Ege MJ, Bieli C, Frei R et al. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J. Allergy Clin. Immunol. 117(4), 817-823 (2006).
73. Roduit C, Wohlgensinger J, Frei R et al. Prenatal animal contact and gene expression of innate immunity receptors at birth are associated with atopic dermatitis. J. Allergy Clin. Immunol. 127(1), 179-185, 185 e171 (2011).
74. Strachan DP. Hay fever, hygiene, and household size. BMJ 299(6710), 1259-1260 (1989). (Pubitemid 19280051)
75. Thornton CA, Macfarlane TV, Holt PG. The hygiene hypothesis revisited: role of materno-fetal interactions. Curr. Allergy Asthma Rep. 10(6), 444-452 (2010).
76. Schaub B, Liu J, Hoppler S et al. Maternal farm exposure modulates neonatal immune mechanisms through regulatory T cells. J. Allergy Clin. Immunol. 123(4), 774-782 e775 (2009).
77. Pfefferle PI, Buchele G, Blumer N et al. Cord blood cytokines are modulated by maternal farming activities and consumption of farm dairy products during pregnancy: the PASTURE Study. J. Allergy Clin. Immunol. 125(1), 108-115 e1-e3 (2010).
78. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 307(5717), 1915-1920 (2005). (Pubitemid 40404694)
79. Sellon RK, Tonkonogy S, Schultz M et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin- 10-deficient mice. Infect. Immun. 66(11), 5224-5231 (1998). (Pubitemid 29044613)
80. Helgeland L, Brandtzaeg P. Development and function of intestinal B and T cells. Microbiol. Ecol. Health Dis. 12(2), S110-S127 (2000).
81. Yamanaka T, Helgeland L, Farstad IN, Fukushima H, Midtvedt T, Brandtzaeg P. Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer's patches. J. Immunol. 170(2), 816-822 (2003). (Pubitemid 36070533)
82. Guarner F, Bourdet-Sicard R, Brandtzaeg P et al. Mechanisms of disease: the hygiene hypothesis revisited. Nat. Clin. Pract. Gastroenterol. Hepatol. 3(5), 275-284 (2006). (Pubitemid 43675024)
83. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol.108(4), 516-520 (2001). (Pubitemid 32978019)
84. Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases. Inflamm. Bowel Dis. 14(11), 1585-1596 (2008).
85. van Baarlen P, Troost FJ, van Hemert S et al. Differential NF-kB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc. Natl Acad. Sci. USA 106(7), 2371-2376 (2009).
86. Roselli M, Finamore A, Nuccitelli S et al. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gdT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflamm. Bowel Dis. 15(10), 1526-1536 (2009).
87. Kukkonen K, Savilahti E, Haahtela T et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J. Allergy Clin. Immunol. 119(1), 192-198 (2007). (Pubitemid 46037805)
88. Alfaleh K, Bassler D. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. (1), CD005496 (2008).
89. Lohsoonthorn V, Qiu C, Williams MA. Maternal serum C-reactive protein concentrations in early pregnancy and subsequent risk of preterm delivery. Clin. Biochem. 40(5-6), 330-335 (2007).
90. Tjoa ML, van Vugt JM, Go AT, Blankenstein MA, Oudejans CB, van Wijk IJ. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J. Reprod. Immunol. 59(1), 29-37 (2003). (Pubitemid 36918498)
91. Morales E, Guerra S, Garcia-Esteban R et al. Maternal C-reactive protein levels in pregnancy are associated with wheezing and lower respiratory tract infections in the offspring. Am. J. Obstet. Gynecol. 204(2), 164 e161-169 (2011).
92. Bearfield C, Davenport ES, Sivapathasundaram V, Allaker RP. Possible association between amniotic fluid micro-organism infection and microflora in the mouth. BJOG 109(5), 527-533 (2002). (Pubitemid 37337993)
93. Madianos PN, Lieff S, Murtha AP et al. Maternal periodontitis and prematurity, Part II: maternal infection and fetal exposure. Obstet. Gynecol. Surv. 58(7), 438-440 (2001).
94. Jeffcoat MK, Geurs NC, Reddy MS, Cliver SP, Goldenberg RL, Hauth JC. Periodontal infection and preterm birth: results of a prospective study. J. Am. Dent. Assoc. 132(7), 875-880 (2001).
95. Dortbudak O, Eberhardt R, Ulm M, Persson GR. Periodontitis, a marker of risk in pregnancy for preterm birth. J. Clin. Periodontol. 32(1), 45-52 (2005). (Pubitemid 40187425)
96. Offenbacher S, Katz V, Fertik G et al. Periodontal infection as a possible risk factor for preterm low birth weight. J. Periodontol. 67(10 Suppl.), 1103-1113 (1996). (Pubitemid 126613091)
97. Goepfert AR, Jeffcoat MK, Andrews WW et al. Periodontal disease and upper genital tract inflammation in early spontaneous preterm birth. Obstet. Gynecol. 104(4), 777-783 (2004). (Pubitemid 40458808)
98. Jared H, Boggess KA, Moss K et al. Fetal exposure to oral pathogens and subsequent risk for neonatal intensive care admission. J. Periodontol. 80(6), 878-883 (2009).
99. Polyzos NP, Polyzos IP, Zavos A et al. Obstetric outcomes after treatment of periodontal disease during pregnancy: systematic review and meta-analysis. BMJ 341, c7017 (2010).
100. Uppal A, Uppal S, Pinto A et al. The effectiveness of periodontal disease treatment during pregnancy in reducing the risk of experiencing preterm birth and low birth weight: a meta-analysis. J. Am. Dent. Assoc. 141(12), 1423-1434 (2010).
101. Jeffcoat M, Parry S, Sammel M, Clothier B, Catlin A, Macones G. Periodontal infection and preterm birth: successful periodontal therapy reduces the risk of preterm birth. BJOG 118(2), 250-256 (2011).
102. Klebanoff M, Searle K. The role of inflammation in preterm birth - focus on periodontitis. BJOG 113(Suppl. 3), 43-45 (2006). (Pubitemid 44934665)
103. Holst D, Garnier Y. Preterm birth and inflammation - the role of genetic polymorphisms. Eur. J. Obstet. Gynecol. Reprod. Biol. 141(1), 3-9 (2008).
104. Salminen A, Paananen R, Vuolteenaho R et al. Maternal endotoxin-induced preterm birth in mice: fetal responses in Toll-like receptors, collectins, and cytokines. Pediatr. Res. 63(3), 280-286 (2008). (Pubitemid 351301457)
105. Jamieson DJ, Honein MA, Rasmussen SA et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 374(9688), 451-458 (2009).
106. Hardy JM, Azarowicz EN, Mannini A, Medearis DN Jr, Cooke RE. The effect of Asian influenza on the outcome of pregnancy, Baltimore, 1957-1958. Am. J. Public Health Nations Health 51, 1182-1188 (1961).
107. Siegel M, Fuerst HT, Peress NS. Comparative fetal mortality in maternal virus diseases. A prospective study on rubella, measles, mumps, chicken pox and hepatitis. N. Engl. J. Med. 274(14), 768-771 (1966).
108. Markenson GR, Yancey MK. Parvovirus B19 infections in pregnancy. Semin. Perinatol. 22(4), 309-317 (1998). (Pubitemid 28397552)
109. O'Callaghan E, Sham P, Takei N, Glaver G, Murray RM. Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet 337, 1248-1251 (1991).
110. Brown AS, Begg MD, Gravenstein S et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 61(8), 774-780 (2004). (Pubitemid 39031117)
111. Jordan JA, Huff D, DeLoia JA. Placental cellular immune response in women infected with human parvovirus B19 during pregnancy. Clin. Diagn Lab. Immunol. 8(2), 288-292 (2001). (Pubitemid 32217058)
112. Abrahams VM, Schaefer TM, Fahey JV et al. Expression and secretion of antiviral factors by trophoblast cells following stimulation by the TLR-3 agonist, poly(I:C). Hum. Reprod. 21(9), 2432-2439 (2006). (Pubitemid 44530624)
113. Ilievski V, Lu SJ, Hirsch E. Activation of Toll-like receptors 2 or 3 and preterm delivery in the mouse. Reprod. Sci. 14(4), 315-320 (2007). (Pubitemid 351168807)
114. Cardenas I, Mor G, Aldo P et al. Placental viral infection sensitizes to endotoxin-induced pre-term labor: a double hit hypothesis. Am. J. Reprod. Immunol. 65(2), 110-117 (2011).
115. Cardenas I, Means RE, Aldo P et al. Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J. Immunol. 185(2), 1248-1257 (2010).
116. Pereira L, Maidji E, McDonagh S, Tabata T. Insights into viral transmission at the uterine-placental interface. Trends Microbiol. 13(4), 164-174 (2005). (Pubitemid 40463318)
117. Chaudhuri S, Lowen B, Chan G, Davey A, Riddell M, Guilbert LJ. Human cytomegalovirus interacts with Toll-like receptor 2 and CD14 on syncytiotrophoblasts to stimulate expression of TNFa mRNA and apoptosis. Placenta 30(11), 994-1001 (2009).
118. World Health Organization. Africa Malaria Report. WHO, Geneva, Switzerland (2003).
119. Steketee RW, Wirima JJ, Campbell CC. Developing effective strategies for malaria prevention programs for pregnant African women. Am. J. Trop. Med. Hyg. 55(1 Suppl.), 95-100 (1996).
120. Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am. J. Trop. Med. Hyg. 64(1-2 Suppl.), 28-35 (2001). (Pubitemid 32552569)
121. Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272(5267), 1502-1504 (1996). (Pubitemid 26200005)
122. Schwarz NG, Adegnika AA, Breitling LP et al. Placental malaria increases malaria risk in the first 30 months of life. Clin. Infect. Dis. 47(8), 1017-1025 (2008).
123. Fievet N, Varani S, Ibitokou S et al. Plasmodium falciparum exposure in utero, maternal age and parity influence the innate activation of foetal antigen presenting cells. Malar. J. 8, 251 (2009).
124. Breitling LP, Fendel R, Mordmueller B, Adegnika AA, Kremsner PG, Luty AJ. Cord blood dendritic cell subsets in African newborns exposed to Plasmodium falciparum in utero. Infect. Immun. 74(10), 5725-5729 (2006). (Pubitemid 44484557)
125. Dombrowski MP, Schatz M, Wise R et al. Asthma during pregnancy. Obstet. Gynecol. 103(1), 5-12 (2004). (Pubitemid 39248459)
126. Demissie K, Breckenridge MB, Rhoads GG. Infant and maternal outcomes in the pregnancies of asthmatic women. Am. J. Respir. Crit. Care Med. 158, 1091-1095 (1998). (Pubitemid 28489006)
127. Kallen B, Rydhstroem H, Aberg A. Asthma during pregnancy - a population based study. Eur. J. Epidemiol.16(2), 167-171 (2000). (Pubitemid 30322123)
128. Clifton V. Maternal asthma during pregnancy and fetal outcomes: potential mechanisms and possible solutions. Curr. Opin. Allergy Clin. Immunol. 6(5), 307-311 (2006). (Pubitemid 44368234)
129. Clifton VL, Engel P, Smith R, Gibson P, Brinsmead M, Giles WB. Maternal and neonatal outcomes of pregnancies complicated by asthma in an Australian population. Aust. NZ J. Obstet. Gynaecol. 49(6), 619-626 (2009).
130. Liu S, Wen SW, Demissie K, Marcoux S, Kramer MS. Maternal asthma and pregnancy outcomes: a retrospective cohort study. Am. J. Obstet. Gynecol. 184(2), 90-96 (2001). (Pubitemid 32141649)
131. Murphy VE, Clifton VL, Gibson PG. Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax 61(2), 169-176 (2006). (Pubitemid 43235435)
132. Lao TT, Huengsburg M. Labour and delivery in mothers with asthma. Eur. J. Obstet. Gynecol. Reprod. Biol. 35(2-3), 183-190 (1990). (Pubitemid 20184060)
133. Enriquez R, Griffin MR, Carroll KN et al. Effect of maternal asthma and asthma control on pregnancy and perinatal outcomes. J. Allergy Clin. Immunol. 120(3), 625-630 (2007). (Pubitemid 47320762)
134. Schatz M, Zeiger RS, Hoffman CP. Intrauterine growth is related to gestational pulmonary function in pregnant asthmatic women. Kaiser-Permanente Asthma and Pregnancy Study Group. Chest 98(2), 389-392 (1990). (Pubitemid 20247977)
135. Bahna SL, Bjerkedal T. The course and outcome of pregnancy in women with bronchial asthma. Acta Allergol. 27(5), 397-406 (1972).
136. Sears MR, Holdaway MD, Flannery EM, Herbison GP, Silva PA. Parental and neonatal risk factors for atopy, airway hyper-responsiveness, and asthma. Arch. Dis. Child. 75(5), 392-398 (1996). (Pubitemid 26405678)
137. Murphy VE, Gibson PG, Giles WB et al. Maternal asthma is associated with reduced female fetal growth. Am. J. Respir. Crit. Care Med. 168, 1317-1323 (2003). (Pubitemid 37487326)
138. Magnusson CGM. Cord serum IgE in relation to family history and as predictor of atopic disease in early infancy. Allergy 43, 241-251 (1988).
139. Liu CA, Wang CL, Chuang H, Ou CY, Hsu TY, Yang KD. Prenatal prediction of infant atopy by maternal but not paternal total IgE levels. J. Allergy Clin. Immunol. 112(5), 899-904 (2003). (Pubitemid 37412057)
140. Shah PS, Wegienka G, Havstad S, Johnson CC, Ownby DR, Zoratti EM. The relationship between cord blood immunoglobulin E levels and allergy-related outcomes in young adults. Ann. Allergy Asthma Immunol. 106(3), 245-251 (2011).
141. Reece P, Thanendran A, Crawford L et al. Maternal allergy modulates cord blood hematopoietic progenitor Toll-like receptor expression and function. J. Allergy Clin. Immunol. 127(2), 447-453 (2011).
142. Grzela K, Grzela T, Korczak-Kowalska G et al. Risk of allergy development correlates with IL-4 receptor expression on newborns' monocytes and Th lymphocytes. Med. Sci. Monit. 13(10), CR445-CR448 (2007).
143. Osei-Kumah A, Smith R, Clifton VL. Maternal and cord plasma cytokine and chemokine profile in pregnancies complicated by asthma. Cytokine 43(2), 187-193 (2008).
144. Ponath PD, Qin S, Ringler DJ et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97(3), 604-612 (1996). (Pubitemid 26057077)
145. Friedlander SL, Jackson DJ, Gangnon RE et al. Viral infections, cytokine dysregulation and the origins of childhood asthma and allergic diseases. Pediatr. Infect. Dis. J. 24(11 Suppl.), S170-S176, discussion S174-S175 (2005).
146. Copenhaver CC, Gern JE, Li Z et al. Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am. J. Respir. Crit. Care Med. 170(2), 175-180 (2004). (Pubitemid 38925164)
147. Macaubas C, de Klerk NH, Holt BJ et al. Association between antenatal cytokine production and the development of atopy and asthma at age 6 years. Lancet 362(9391), 1192-1197 (2003). (Pubitemid 37255345)
148. Prescott SL, Noakes P, Chow BW et al. Presymptomatic differences in Toll-like receptor function in infants who have allergy. J. Allergy Clin. Immunol. 391-399, 399 e1-e5 (2008).
149. Scott N, Hodyl N, Osei-Kumah A, Stark M, Smith R, Clifton V. The presence of maternal asthma during pregnancy suppresses the placental proinflammatory response to an immune challenge in vitro. Placenta 32, 454-461 (2011).
150. Scott N, Hodyl N, Murphy V et al. Placental cytokine expression covaries with maternal asthma severity and fetal sex. J. Immunol. 182(3), 1411-1420 (2009).
151. Msall ME, Buck GM, Rogers BT et al. Multivariate risks among extremely premature infants. J. Perinatol. 14(1), 41-47 (1994).
152. Mwanyumba F, Inion I, Gaillard P, Mandaliya K, Praet M, Temmermen M. Placental inflammation and perinatal outcome. Eur. J. Obstet. Gynecol. Reprod. Biol. 108, 164-170 (2003). (Pubitemid 36629343)
153. Moss TJ, Nitsos I, Kramer BW, Ikegami M, Newnham JP, Jobe AH. Intra-amniotic endotoxin induces lung maturation by direct effects on the developing respiratory tract in preterm sheep. Am. J. Obstet. Gynecol. 187(4), 1059-1065 (2002). (Pubitemid 35178411)
154. Kallapur SG, Willet KE, Jobe AH, Ikegami M, Bachurski CJ. Intra-amniotic endotoxin: chorioamnionitis precedes lung maturation in preterm lambs. Am. J. Physiol. Lung Cell. Mol. Physiol. 280(3), L527-L536 (2001).
155. Willet KE, Kramer BW, Kallapur SG et al. Intra-amniotic injection of IL-1 induces inflammation and maturation in fetal sheep lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 282(3), L411-L420 (2002). (Pubitemid 34654643)
156. Kallapur SG, Nitsos I, Moss TJ et al. IL-1 mediates pulmonary and systemic inflammatory responses to chorioamnionitis induced by lipopolysaccharide. Am. J. Respir. Crit. Care Med. 179(10), 955-961 (2009).
157. Getahun D, Ananth CV, Kinzler WL. Risk factors for antepartum and intrapartum stillbirth: a population-based study. Am. J. Obstet. Gynecol. 196(6), 499-507 (2007). (Pubitemid 46836591)
158. Goldenberg RL, Hauth JC, Andrews WW. Mechanisms of disease: intrauterine infection and preterm delivery. N. Eng. J. Med. 342(20), 1500-1507 (2000). (Pubitemid 30318275)
159. Gibbs RS. The relationship between infections and adverse pregnancy outcomes: an overview. Ann. Periodontol. 6(1), 153-163 (2001).
160. Marret S, Ancel PY, Marpeau L et al. Neonatal and 5-year outcomes after birth at 30-34 weeks of gestation. Obstet. Gynecol. 110(1), 72-80 (2007). (Pubitemid 47015703)
161. Getahun D, Strickland D, Zeiger RS et al. Effect of chorioamnionitis on early childhood asthma. Arch. Pediatr. Adolesc. Med. 164(2), 187-192 (2010).
162. Goepfert AR, Andrews WW, Carlo W et al. Umbilical cord plasma interleukin-6 concentrations in preterm infants and risk of neonatal morbidity. Am. J. Obstet. Gynecol. 191(4), 1375-1381 (2004). (Pubitemid 39421599)
163. Salafia CM, Sherer DM, Spong CY et al. Fetal but not maternal serum cytokine levels correlate with histologic acute placental inflammation. Am J. Perinatol. 14(7), 419-422 (1997). (Pubitemid 27329086)
164. Kumazaki K, Nakayama M, Yanagihara I, Suehara N, Wada Y. Immunohistochemical distribution of Toll-like receptor 4 in term and preterm human placentas from normal and complicated pregnancy including chorioamnionitis. Hum. Pathol. 35(1), 47-54 (2004). (Pubitemid 38133922)
165. Vatten LJ, Skjaerven R. Offspring sex and pregnancy outcome by length of gestation. Early Hum. Dev. 76(1), 47-54 (2004). (Pubitemid 38058795)
166. Di Renzo GC, Rosati A, Sarti RD, Cruciani L, Cutuli AM. Does fetal sex affect pregnancy outcome? Gend. Med. 4(1), 19-30 (2007). (Pubitemid 46917064)
167. Engel PJ, Smith R, Brinsmead MW, Bowe SJ, Clifton VL. Male sex and pre-existing diabetes are independent risk factors for stillbirth. Aust. NZ J. Obstet. Gynaecol. 48(4), 375-383 (2008).
168. Ingemarsson I. Gender aspects of preterm birth. BJOG 110, 34-38 (2003). (Pubitemid 36577382)
169. Zeitlin J, Saurel-Cubizolles MJ, De Mouzon J. Fetal sex and preterm birth: are males at greater risk? Hum. Reprod. 17, 2762-2768 (2002). (Pubitemid 35174133)
170. Stark M, Hodyl N, Wright I, Clifton V. The Influence of sex and antenatal betamethasone exposure on vasoconstrictors and the preterm microvasculature. Fetal Neonat. Med. DOI: 10.3109/14767058.2011.569618 (2011) (Epub ahead of print).
171. Stark MJ, Clifton VL, Wright IMR. Sex-specific differences in peripheral microvascular blood flow in preterm infants. Pediatr. Res. 63(4), 415-419 (2008). (Pubitemid 351450589)
172. Stark MJ, Clifton VL, Wright IMR. Microvascular blood flow, clinical illness severity and cardiovascular function in preterm's. Arch. Dis. Child Fetal Neonat. Ed. 93, F271-F274 (2008). (Pubitemid 352039396)
173. Stark M, Clifton V, Wright I. Carbon monoxide is a significant mediator of cardiovascular status following preterm birth. Pediatrics 124(1), 277-284 (2009).
174. Stark MJ, Wright IMR, Clifton VL. Sex specific alterations in placental 11βhydroxysteroid dehydrogenase 2 activity and early postnatal clinical course following antenatal betamethasone Am. J. Physiol. Regul. Integr. Comp. Physiol. 297(2), R510-R514. (2009).
175. Fameli M, Kitraki E, Stylianopoulou F. Effects of hyperactivity of the maternal hypothalamic-pituitary-adrenal (HPA) axis during pregnancy on the development of the HPA axis and brain monoamines of the offspring. J. Dev. Neurosci. 112, 651-659 (1994). (Pubitemid 24359115)
176. Goatz F, Doarner G, Malz U et al. Short- and long-term effects of perinatal interleukin-1b application in rats. Neuroendocrinology 58, 344-351 (1993). (Pubitemid 23308001)
177. McCormick CM, Smythe JW, Sharma S, Meaney MJ. Sex-specific effects of prenatal stress on hypothalamic-pituitaryadrenal responses to stress and brain glucocorticoid receptor density in adult rats. Brain Res. 84, 55-61 (1995).
178. Gotz F, Dorner G, Malz U et al. Short- and long-term effects of perinatal interleukin-1 βapplication in rats. Neuroendocrinology 58(3), 344-351 (1993). (Pubitemid 23308001)
179. Zhang Y, Cazakoff BN, Thai CA, Howland JG. Prenatal exposure to a viral mimetic alters behavioural flexibility in male, but not female, rats. Neuropharmacology DOI:10.1016/j. neuropharm.2011.02.022 (2011) (Epub ahead of print).
180. Clifton VL, Vanderlelie J, Perkins AV. Increased anti-oxidant enzyme activity and biological oxidation in placentae of pregnancies complicated by maternal asthma. Placenta 26(10), 773-779 (2005). (Pubitemid 41535484)
181. Schroder J, Kahlke V, Staubach KH, Zabel P, Stuber F. Gender differences in human sepsis. Arch. Surg. 133, 1200-1205 (1998). (Pubitemid 28516271)
182. Imahara SD, Jelacic S, Junker CE, O'Keefe GE. The influence of gender on human innate immunity. Surgery 138, 275-282 (2005). (Pubitemid 41253811)
183. Spolarics Z. The X-files of inflammation: cellular mosaicism of X-linked polymorphic genes and the female advantage in the host response to injury and infection. Shock 27(6), 597-604 (2007). (Pubitemid 46788157)
184. Yeganegi M, Watson CS, Martins A et al. Effect of Lactobacillus rhamnosus GR-1 supernatant and fetal sex on lipopolysaccharide-induced cytokine and prostaglandin-regulating enzymes in human placental trophoblast cells: implications for treatment of bacterial vaginosis and prevention of preterm labor. Am. J. Obstet. Gynecol. 200(5), e1-e8 (2009).
185. Stevenson DK, Verter J, Fanaroff AA. Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage. Arch. Dis. Childhood Fetal Neonat. Ed. 83, F182-F185 (2000).
186. Ingemarrsson I. Gender aspects of preterm birth. BJOG 110(Suppl. 20), 34-38 (2003).
187. Ghidini A, Salafia CM. Histologic placental lesions in women with recurrent preterm delivery. Acta. Obstet. Gynecol. Scand. 84(6), 547-550 (2005). (Pubitemid 40756427)
188. Goldenberg RL, Andrews WW, Faye- Petersen OM, Goepfert AR, Cliver SP, Hauth JC. The Alabama Preterm Birth Study: intrauterine infection and placental histologic findings in preterm births of males and females less than 32 weeks. Am. J. Obstet. Gynecol. 195(6), 1533-1537 (2006). (Pubitemid 44792632)
189. Marzi M, Vigano A, Trabattoni D et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin. Exp. Immunol. 106(1), 127-133 (1996). (Pubitemid 26329391)
190. + monocytes in response to sepsis-related antigens. Clin. Exp. Immunol. 141(2), 270-278 (2005). (Pubitemid 41003351)
191. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 373(9678), 1905-1917 (2009).
192. Silverman MN, Sternberg EM. Neuroendocrine-immune interactions in rheumatoid arthritis: mechanisms of glucocorticoid resistance. Neuroimmunomodulation 15(1), 19-28 (2008).
193. Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Ann. Rev. Immunol. 20, 125-163 (2002). (Pubitemid 34295785)
194. National Institutes of Health. The effect of antenatal steroids for fetal maturation on perinatal outcomes-interim draft statement. NIH Consensus Statement 12(2), 1-24 (1994).
195. Willet KE, Jobe AH, Ikegami M et al. Postnatal lung function after prenatal steroid treatment in sheep: effect of gender. Pediatr. Res. 42, 885-892 (1997). (Pubitemid 27509552)
196. Weitzel HK, Lorenz U, Kipper B. Clinical aspects of antenatal glucocorticoid treatment for prevention of neonatal respiratory distress syndrome. J. Perinat. Med. 15, 441-446 (1987). (Pubitemid 18035074)
197. Kramer BW. Antenatal betamethasone changes cord blood monocyte responses to endotoxin in preterm lambs. Pediatr. Res. 55, 764-768 (2004). (Pubitemid 38520441)
198. Kallapur SG, Kramer BW, Moss TJ. Maternal glucocorticoids increase endotoxin-induced lung inflammation in preterm lambs. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L633-L642 (2003). (Pubitemid 36343311)
199. Turner JD, Muller CP. Structure of the glucocorticoid receptor (NR3C1) gene untranslated region: identification, and tissue distribution of multiple new human exon 1. J. Mol. Endocrinol. 35(2), 283-292 (2005). (Pubitemid 41556176)
200. Presul E. Identification, tissue expression, and glucocorticoid responsiveness of alternative first exons of the human glucocorticoid receptor. J. Mol. Endocrinol. 38(1-2), 79-90 (2007). (Pubitemid 46351594)
201. Geng CD, Vedeckis WV. Steroid-responsive sequences in the human glucocorticoid receptor gene 1A promoter. Mol. Endocrinol. 18(4), 912-924 (2004). (Pubitemid 38429481)
202. Purton JF. Expression of the glucocorticoid receptor from the 1A promoter correlates with T lymphocyte sensitivity to glucocorticoid-induced cell death. J. Immunol. 173(6), 3816-3824 (2004). (Pubitemid 39280744)
203. Johnson RF, Rennie N, Murphy V, Zakar T, Clifton V, Smith R. Expression of glucocorticoid receptor mRNA transcripts in the human placenta at term. J. Clin. Endocrinol. Metab. 93(12), 4887-4893 (2008).
204. Turner JD. Highly individual methylation patterns of alternative glucocorticoid receptor promoters suggest individualized epigenetic regulatory mechanisms. Nucleic Acids Res. 36(22), 7207-7218 (2008).
205. Oberlander TF. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 3(2), 97-106 (2008).
206. van Bel F, Heijnen CJ. Perinatal programming and reprogramming by glucocorticoid therapy and perinatal stress. Semin. Fetal Neonatal. Med. 14(3), 127-129 (2009).
207. Hodyl NA, Stark M, Osei-Kumah A, Bowman M, Gibson P, Clifton VL. Fetal glucocorticoid regulated pathways are not affected by inhaled corticosteroid use for asthma during pregnancy. Am. J. Respir. Crit. Care Med. 183(6), 716-722 (2010).
208. Fritz JH, Le Bourhis L, Sellge G et al. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 26(4), 445-459 (2007). (Pubitemid 46604867)
209. Stout RD, Bottomly K. Antigen-specific activation of effector macrophages by IFN-g producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages. J. Immunol. 142(3), 760-765 (1989). (Pubitemid 19093903)
210. Duffield JS. The inflammatory macrophage: a story of Jekyll and Hyde. Clin. Sci. (Lond.) 104(1), 27-38 (2003). (Pubitemid 36249921)
211. Kim KD, Zhao J, Auh S et al. Adaptive immune cells temper initial innate responses. Nat. Med. 13(10), 1248-1252 (2007). (Pubitemid 47530627)